KARACHI – The Maternal & Child Health Integrated Program (MCHIP/Jhpiego) – a USAID funded project – signed a Memorandum of Understanding (MoU) with corporate partner Pfizer Pakistan Limited which allows them to collaborate in improving maternal and neonatal mortality together on 20 October 2014.
The two parties plan to work together to increase access to essential drugs, providing information to new mothers through a ‘Mother’s Booklet’ and increasing awareness of the importance of micronutrients such as iron-folic acid through Lady Health Workers.
The signing ceremony was held at MCHIP/Jhpiego head office in Karachi. The participants included Pfizer Country Manager, Dr. Farid Khan and Chief of Party MCHIP/Jhpiego, Dr. Farid Midhet.
According to the 2006-2007 Pakistan Demographic and Health Survey, Pakistan’s maternal mortality ratio is 276 per 100,000 live births – one of the highest in South Asia. Most of these deaths are preventable. Providing access to properly trained and supported midwives in a functional health system is a key to reducing that number.
MCHIP, led by Jhpiego (an affiliate of Johns Hopkins University USA) in collaboration with Save the Children USA, is implementing the Maternal, Newborn and Child Health (MNCH) Services Project. It is a component of the larger USAID/Pakistan’s Maternal and Child Health (MCH) Program. The project aims to improve access for women and children to health services by strengthening existing health sector facilities and networks in the Sindh Province.
Pfizer is a pharmaceutical, specializing in the production of world class treatments in key therapeutic areas such as Cardiovascular, Pain Management, Central Nervous System and in the advancement of medical and disease related education and awareness in Pakistan.